Previous close | 3.0000 |
Open | 3.0000 |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 360.00 |
Expiry date | 2024-11-15 |
Day's range | 3.0000 - 3.0000 |
Contract range | N/A |
Volume | |
Open interest | 6 |
United Therapeutics Corp, a biotechnology firm, focuses on the development and commercialization of unique products to address the unmet medical needs of patients with chronic and life-threatening conditions. Over the past year, Christopher Causey has engaged in multiple transactions, selling a total of 12,640 shares and purchasing none. Shares of United Therapeutics Corp were priced at $304.18 on the day of the sale.
Director Judy Olian sold 1,700 shares of United Therapeutics Corp (NASDAQ:UTHR) on June 17, 2024, as reported in a recent SEC Filing.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.